The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
| GCIAX | VTSNX | GCIAX / VTSNX | |
| Total Expense Ratio | 1.16 | 0.06 | 1,933% |
| Annual Report Gross Expense Ratio | 1.19 | 0.06 | 1,983% |
| Fund Existence | 29 years | 16 years | - |
| Gain YTD | 14.734 | 15.989 | 92% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.22B | 646B | 1% |
| Annual Yield % from dividends | 1.21 | 2.50 | 48% |
| Returns for 1 year | 18.68 | 23.60 | 79% |
| Returns for 3 years | 66.54 | 60.94 | 109% |
| Returns for 5 years | 48.28 | 37.06 | 130% |
| Returns for 10 years | 130.41 | 99.23 | 131% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFNIX | 91.57 | 0.43 | +0.47% |
| Janus Henderson Global Life Sciences I | |||
| PNBAX | 31.92 | N/A | N/A |
| Virtus NFJ Large-Cap Value A | |||
| PEEAX | 13.34 | N/A | N/A |
| PGIM Jennison Mid-Cap Growth A | |||
| MNOPX | 34.37 | N/A | N/A |
| Morgan Stanley Inst International Opp R6 | |||
| RSMVX | 13.55 | N/A | N/A |
| William Blair Small-Mid Cap Value R6 | |||